Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

CompletedOBSERVATIONAL
Enrollment

188

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Methicillin-Resistant Staphylococcus Aureus (MRSA)Hospital-Acquired Pneumonia
Interventions
DRUG

Linezolid

Patients with documented MRSA hospital-acquired or ventilator-associated pneumonia treated with linezolid according to routine medical care.

DRUG

Vancomycin

Patients with documented MRSA hospital-acquired or ventilator-associated pneumonia treated with vancomycin according to routine medical care.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Louisville

OTHER

collaborator

Henry Ford Hospital

OTHER

collaborator

Summa Health System

OTHER

collaborator

Sparrow Health System

OTHER

collaborator

Jackson Health System

OTHER

lead

Pfizer

INDUSTRY

NCT01561469 - Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin | Biotech Hunter | Biotech Hunter